Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

MyopiaX-1

In this page

Clinical Trial

NCT04967287 Active, Not recruiting
MyopiaX-1

MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

Interventional

Disease

Disease type

Other

Paediatric clinical trials

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

16/11/2021

Closing date

30/04/2024

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Others investigators

Pr Philipp Albrecht

Representative

Germany

See more

Pr Katarina Stingl

Representative

Germany

Low Vision Daily Life and Patients Groups (TWG5), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Dr Alberta Thiadens

Representative

Netherlands

Genetic Diagnostics (TWG6), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Dr Marta Morales Ballús

Representative

Spain

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8)
See more

ERN EYE member investigating site

HCP : Principal investigators

Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany

Adress

Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7

72076 Tübingen

Germany